Aspen Pharmacare Holdings Limited (JSE:APN)

Market Cap	61.78B -19.7%
Revenue (ttm)	42.59B +2.8%
Net Income	-2.00B
EPS	-4.50
Shares Out	444.02M
PE Ratio	n/a
Forward PE	13.54
Dividend	2.11 (1.52%)
Ex-Dividend Date	Oct 1, 2025

Volume	1,140,677
Average Volume	1,582,319
Open	13,965
Previous Close	13,914
Day's Range	13,430 - 14,024
52-Week Range	9,070 - 18,595
Beta	0.37
RSI	69.61
Earnings Date	Mar 3, 2026

About Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counte...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1850
• Employees: 9,557
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: APN